Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 752.11Cr 112.72Cr 100.8Cr 93Cr 84Cr 158.03Cr 11TCr 160.62Cr 1.12TCr 443.88Cr 5.61TCr 423.06Cr 414.02Cr 18TCr P/E 2026 *
16.7x
P/E 2027 * 14x
Enterprise Value 628.23Cr 94Cr 84Cr 78Cr 71Cr 132Cr 8.96TCr 134.16Cr 937.34Cr 370.77Cr 4.69TCr 353.38Cr 345.83Cr 15TCr EV / Sales 2026 *
0.36x
EV / Sales 2027 * 0.33x
Free-Float
51.88%
Yield 2026 *
2.75%
Yield 2027 * 3.76%
1 day+3.23%
1 week-1.06%
Current month+22.20%
1 month+23.58%
3 months+19.63%
6 months+4.47%
Current year+1.87%
1 week 12.57
Extreme 12.57
13.42
1 month 10.59
Extreme 10.59
13.42
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Director/Board Member 62 01/11/2013
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Date Insider Type Main position Quantity % Market Cap. Importance
12/05/26 Buy

Founder

13,59,000 0.3397%
12/05/26 Sell

Founder

-27,27,600 0.6818%
11/05/26 Sell

Founder

-88,06,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+3.23%-1.06%-5.55%-38.53% 109.23Cr
+0.16%-2.33%-39.74%+12.42% 1.53TCr
-14.39%-26.38%-18.16%-38.93% 703.93Cr
-2.35%-0.06%-10.09%-0.12% 658.17Cr
-1.58%-2.01%-16.82%+3.07% 644.18Cr
-0.70%-5.32%-51.94%-36.35% 590.56Cr
+0.67%+0.63%+1.27%-3.48% 460.95Cr
-0.91%-3.52%-13.76%-16.74% 320.96Cr
+4.63%-0.37%+1.71%-17.68% 310.06Cr
+2.95%-7.78%-40.61%-14.82% 302.36Cr
Average -0.86%-1.25%-19.37%-15.12% 562.96Cr
Weighted average by Cap. -1.83%-1.33%-24.49%-8.73%

Financials

2026 *2027 *
Net sales 1.76TCr 263.34Cr 235.48Cr 217.86Cr 197.26Cr 369.19Cr 25TCr 375.24Cr 2.62TCr 1.04TCr 13TCr 988.38Cr 967.26Cr 41TCr 1.86TCr 278.56Cr 249.08Cr 230.45Cr 208.65Cr 390.51Cr 27TCr 396.91Cr 2.77TCr 1.1TCr 14TCr 1.05TCr 1.02TCr 44TCr
Net income 46Cr 6.84Cr 6.11Cr 5.66Cr 5.12Cr 9.58Cr 650.46Cr 9.74Cr 68Cr 27Cr 340.22Cr 26Cr 25Cr 1.08TCr 55Cr 8.19Cr 7.33Cr 6.78Cr 6.14Cr 11Cr 779.59Cr 12Cr 82Cr 32Cr 407.75Cr 31Cr 30Cr 1.29TCr
Net Debt -123.88Cr -19Cr -17Cr -15Cr -14Cr -26Cr -1.77TCr -26Cr -184.83Cr -73Cr -923.87Cr -70Cr -68Cr -2.93TCr -142.36Cr -21Cr -19Cr -18Cr -16Cr -30Cr -2.03TCr -30Cr -212.41Cr -84Cr -1.06TCr -80Cr -78Cr -3.36TCr
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
26/26/26 CN¥13.10 +3.23% 1,65,85,949
23/26/23 CN¥12.69 -2.16% 1,48,80,243
22/26/22 CN¥12.97 -2.11% 1,55,43,072
21/26/21 CN¥13.25 +1.30% 1,56,53,930
20/26/20 CN¥13.08 -1.21% 2,16,57,600
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.10CNY
Average target price
13.19CNY
Spread / Average Target
+0.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock